Advisors Asset Management, Inc. Sarepta Therapeutics, Inc. Transaction History

Advisors Asset Management, Inc.

$5.28 Billion
Q3 2024

A detailed history of Advisors Asset Management, Inc. transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Advisors Asset Management, Inc. holds 14,869 shares of SRPT stock, worth $1.77 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

14,869

Previous 14,826 0.29%

Holding current value

$1.77 Million

Previous $2.34 Million 20.71%

% of portfolio

0.04%

Previous 0.05%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$124.33 - $156.75 $5,346 - $6,740	43 Added 0.29%	14,869 $1.86 Million
Q2 2024 Aug 14, 2024	BUY	$113.33 - $163.85 $76,497 - $110,598	675 Added 4.77%	14,826 $2.34 Million
Q1 2024 May 14, 2024	BUY	$93.7 - $141.53 $68,963 - $104,166	736 Added 5.49%	14,151 $1.83 Million
Q4 2023 Feb 14, 2024	SELL	$67.31 - $124.76 $535,383 - $992,341	-7,954 Reduced 37.22%	13,415 $1.29 Million
Q2 2023 Aug 14, 2023	BUY	$106.4 - $157.19 $416,024 - $614,612	3,910 Added 22.4%	21,369 $2.45 Million
Q1 2023 May 12, 2023	BUY	$117.53 - $155.99 $79,332 - $105,293	675 Added 4.02%	17,459 $2.41 Million
Q4 2022 Feb 13, 2023	BUY	$100.86 - $132.13 $6,555 - $8,588	65 Added 0.39%	16,784 $2.17 Million
Q3 2022 Nov 08, 2022	BUY	$75.71 - $119.24 $454,108 - $715,201	5,998 Added 55.95%	16,719 $1.85 Million
Q2 2022 Aug 08, 2022	SELL	$62.69 - $88.44 $674,795 - $951,968	-10,764 Reduced 50.1%	10,721 $804,000
Q1 2022 May 17, 2022	SELL	$63.15 - $90.42 $144,929 - $207,513	-2,295 Reduced 9.65%	21,485 $1.68 Million
Q4 2021 Feb 15, 2022	BUY	$77.28 - $99.42 $17,697 - $22,767	229 Added 0.97%	23,780 $2.14 Million
Q3 2021 Nov 12, 2021	SELL	$65.97 - $92.48 $12,600 - $17,663	-191 Reduced 0.8%	23,551 $2.18 Million
Q2 2021 Jul 30, 2021	BUY	$69.38 - $86.75 $228,676 - $285,928	3,296 Added 16.12%	23,742 $1.85 Million
Q1 2021 May 07, 2021	BUY	$72.25 - $168.95 $489,204 - $1.14 Million	6,771 Added 49.51%	20,446 $1.52 Million
Q4 2020 Feb 12, 2021	BUY	$125.56 - $178.74 $644,499 - $917,472	5,133 Added 60.09%	13,675 $2.33 Million
Q3 2020 Nov 16, 2020	BUY	$127.12 - $172.34 $466,784 - $632,832	3,672 Added 75.4%	8,542 $1.2 Million
Q2 2020 Aug 12, 2020	BUY	$93.0 - $171.7 $323,733 - $597,687	3,481 Added 250.61%	4,870 $781,000
Q1 2020 May 15, 2020	SELL	$82.38 - $131.64 $43,331 - $69,242	-526 Reduced 27.47%	1,389 $136,000
Q4 2019 Feb 14, 2020	SELL	$76.53 - $135.58 $149,998 - $265,736	-1,960 Reduced 50.58%	1,915 $247,000
Q3 2019 Nov 14, 2019	BUY	$72.81 - $156.91 $3,640 - $7,845	50 Added 1.31%	3,875 $292,000
Q2 2019 Aug 14, 2019	BUY	$112.21 - $151.95 $1,570 - $2,127	14 Added 0.37%	3,825 $581,000
Q1 2019 May 15, 2019	BUY	$106.67 - $151.68 $36,054 - $51,267	338 Added 9.73%	3,811 $454,000
Q4 2018 Jan 31, 2019	BUY	$97.32 - $148.76 $45,740 - $69,917	470 Added 15.65%	3,473 $379,000
Q3 2018 Nov 15, 2018	BUY	$115.31 - $161.51 $346,275 - $485,014	3,003 New	3,003 $485,000

Others Institutions Holding SRPT

# of Institutions

529

Shares Held

84.2M

Call Options Held

2.06M

Put Options Held

1.52M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisors Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisors Asset Management, Inc. with notifications on news.

Account

Advisors Asset Management, Inc. Sarepta Therapeutics, Inc. Transaction History